Globus Medical (GMED) Free Cash Flow Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 6.28% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 9.63% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 22.80% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 29.36% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -27.72% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -0.27% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 77.20% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -20.37% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.32% |
| 10 | Globus Medical | 10.79 Bn | 10.16 Bn | 525.79 Mn | 63.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63.37% |
| Dec 31, 2025 | -4.63% |
| Sep 30, 2025 | 171.21% |
| Jun 30, 2025 | -4.53% |
| Mar 31, 2025 | 51.53% |
| Dec 31, 2024 | 36.97% |
| Sep 30, 2024 | 27.89% |
| Jun 30, 2024 | -63.69% |
| Mar 31, 2024 | -2.00% |
| Dec 31, 2023 | 58.72% |
| Sep 30, 2023 | -79.80% |
| Jun 30, 2023 | 27.17% |
| Mar 31, 2023 | 0.28% |
| Dec 31, 2022 | 26.06% |
| Sep 30, 2022 | -29.89% |
| Jun 30, 2022 | 66.04% |
| Mar 31, 2022 | 54.30% |
| Sep 30, 2021 | 6.75% |
| Jun 30, 2021 | 55.39% |
| Mar 31, 2021 | 7.72% |
| Dec 31, 2020 | -13.32% |
| Sep 30, 2020 | 36.15% |
| Jun 30, 2020 | 21.27% |
| Mar 31, 2020 | -4.07% |
| Dec 31, 2019 | 66.53% |
| Sep 30, 2019 | 36.99% |
| Jun 30, 2019 | -14.33% |
| Mar 31, 2019 | -37.93% |
| Sep 30, 2018 | 50.71% |
| Jun 30, 2018 | 80.70% |
| Mar 31, 2018 | 13.31% |
| Dec 31, 2017 | 85.60% |
| Sep 30, 2017 | -11.97% |
| Jun 30, 2017 | 25.60% |
| Mar 31, 2017 | 22.03% |
| Dec 31, 2016 | -23.83% |
| Sep 30, 2016 | 8.78% |
| Jun 30, 2016 | 64.71% |
| Mar 31, 2016 | 58.94% |
| Dec 31, 2015 | 23.23% |
| Sep 30, 2015 | 16.58% |
| Jun 30, 2015 | -39.75% |
| Mar 31, 2015 | 18.39% |
| Dec 31, 2014 | -34.83% |
| Sep 30, 2014 | 17.85% |